Nizar El-Murr

Years Active: 2019-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Sahar Kassem, Béré K Diallo, Nizar El-Murr, Nadège Carrié, Alexandre Tang, Alain Fournier, Hélène Bonnevaux, Céline Nicolazzi, Marine Cuisinier, Isabelle Arnould, Sukhvinder S Sidhu, Jill Corre, Herve Avet-Loiseau, Jean-Luc Teillaud, Helgi van de Velde, Dmitri Wiederschain, Marielle Chiron, Ludovic Martinet, Angela Virone-Oddos
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma. Blood 139 (8) (2022)
Lan Wu, Edward Seung, Ling Xu, Ercole Rao, Dana M Lord, Ronnie R Wei, Virna Cortez-Retamozo, Beatriz Ospina, Valeriya Posternak, Gregory Ulinski, Peter Piepenhagen, Elisa Francesconi, Nizar El-Murr, Christian Beil, Patrick Kirby, Aiqun Li, Jennifer Fretland, Rita Vicente, Gejing Deng, Tarik Dabdoubi, Beatrice Cameron, Thomas Bertrand, Paul Ferrari, Stéphanie Pouzieux, Cendrine Lemoine, Catherine Prades, Anna Park, Huawei Qiu, Zhili Song, Bailin Zhang, Fangxian Sun, Marielle Chiron, Srinivas Rao, Radošević Katarina, Zhi-Yong Yang, Gary J Nabel
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation. Nature cancer 1 (1) (2019)

Nizar El-Murr.css-eqlu8i{font-size:small;padding-left:4px;}